MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • Davis Meg

    Switzerland

  • Davis Randy

    retired

    United States

  • de Assis Andrade Maria Angélica

    Grupo Esperança

    Brazil

  • de Casas Fernández Carmen

    Spain

  • de Casas Fernández Luz

    ASSCAT

    Spain

  • Dechaboon Jutatip

    Siam Impact Foundation

    Thailand

  • De Courlon Ribeiro Bruno

    France

  • Dee Lynda

    AIDS Action Baltimore

    United States

  • de Feo Moyano María Eugenia

    Fundación HCV Sin Fronteras

    Argentina

  • Defretin Aurélie

    Médecins du monde

    France

  • de Gregorio Cortes Manuel

    CASDA

    Spain

  • de juan ramirez jose

    instituciones penitenciaria

    Spain

  • de la Concepción Sánchez Roger

    Spain

  • De León Alma

    ITPC-LATCA

    Guatemala

  • del fraile pilar

    Spain

  • Delgado Cruz Luis

    Spain

  • Demarque Maria Helena

    Brazil

  • den Broeder mirjam

    Netherlands

  • Denis Maruha

    The league of people living with HIV of Republic of Moldova (League PLHIV)

    Moldova

  • denisova Nana

    Georgia

  • Dennis Karen

    Victoria AIDS Resource & Community Service Society

    Canada

  • de peon salamanca eugenia

    Spain

  • derozier stéphanie

    mdm

    France

  • Desclaux Sall Caroline

    UMI 233-CRCF

    Senegal

  • desmaris Delphine

    France

  • desoky Dr mahmoud

    MINI unuversty hospital

    Egypt

  • de Souza Sebastiao

    Grupo Otimismo

    Brazil

  • Devine Erin

    Australia

  • Dewan Jon

    Metha-User Community

    Nepal

  • Dhuyvetter Cathy

    United States

  • Diallo Abdourahmane Diouria

    SOS hépatites Guinée

    Guinea

  • diamasse vanessa

    CUT

    Mauritius

  • dian adnan

    rumahpeka.org

    Indonesia

  • Dianis Nancy

    Westat

    United States

  • Dibbern jonah

    Germany

  • Didlick John

    ACT Hepatitis Resource Centre

    Australia

  • diego diez carlos

    Spain

  • diez iglesias juan miguel

    gruo optimo

    Spain

  • Di Giano Lorena

    Fundación GEP

    Argentina

  • Dill Anja

    Germany

  • Dillon Sheila

    United States

  • Dixon Ross

    United Kingdom

  • Dobon Lourdes

    Spain

  • Do Dang Dong

    VNP+

    Vietnam

  • Dohmstreich Martin

    AIDS-Hilfe Rhein-Sieg e.V.

    Germany

  • dollinger sylvia

    Germany

  • Dominique Hamelin

    SOS Hépatites

    France

  • Domínguez Jiménez Rosa Domínguez

    Omsida

    Spain

  • Donaldson Nelle

    United States

  • doris felix

    perso

    Mauritius